Prochieve (Progesterone Vaginal 4% Gel) e Hiperlipidemia
Resultado da verificação da interação do medicamento Prochieve (Progesterone Vaginal 4% Gel) com doença Hiperlipidemia quanto a segurança no uso em conjunto.
Na verificação da interação, conforme informações das fontes confiáveis como Drugs.com, Rxlist.com, Webmd.com, Medscape.com, foram identificadas as contra-indicações ou efeitos colaterais que podem prejudicar a saúde ou aumentar efeito negativo ao consumir o medicamento com esta doença concomitante.
Consumidor:Alguns progestogenic agentes podem elevar os níveis de LDL do plasma e/ou menores níveis de HDL, embora os dados têm sido inconsistentes. Pacientes com pré-existentes hiperlipidemia pode exigir acompanhamento mais de perto durante progestagénio terapia, e os ajustes feitos de forma adequada no seu redutor de lípidos regime.
- "Product Information. Ortho-Cyclen (ethinyl estradiol-norgestimate)." Ortho Pharmaceutical Corporation, Raritan, NJ.
- Luciano AA, De Souza MJ, Roy MP, Schoenfeld MJ, Nulsen JC, Halvorson CV "Evaluation of low-dose estrogen and progestin therapy in postmenopausal women." J Reprod Med 38 (1993): 207-14
- "Product Information. Ortho-Cept (desogestrel-ethinyl estradiol)." Ortho Pharmaceutical Corporation, Raritan, NJ.
- "Product Information. Micronor (norethindrone)" Ortho McNeil Pharmaceutical, Raritan, NJ.
- Barnes RB, Roy S, Lobo RA "Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women." Obstet Gynecol 66 (1985): 216-9
- Haiba NA, el-Habashy MA, Said SA, Darwish EA, Abdel-Sayed WS, Nayel SE "Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters." Contraception 39 (1989): 619-32
- Teichmann AT, Wander HE, Cremer P, et al. "Medroxyprogesterone acetate and lipid metabolic changes." Arzneimittelforschung 37 (1987): 573-77
- Virutamasen P, Wongsrichanalai C, Tangkeo P, Nitichai Y, Rienprayoon D "Metabolic effects of depot-medroxyprogesterone acetate in long-term users: a cross-sectional study." Int J Gynaecol Obstet 24 (1986): 291-6
- "Product Information. Ortho Novum 10/11 (ethinyl estradiol-norethindrone)." Ortho Pharmaceutical Corporation, Raritan, NJ.
- "Product Information. Ovrette (norgestrel)" Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Provera (medroxyprogesterone)." Pharmacia and Upjohn, Kalamazoo, MI.
- "Product Information. Triphasil (ethinyl estradiol-levonorgestrel)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Depo-Provera (medroxyprogesterone)." Pharmacia and Upjohn, Kalamazoo, MI.
- "Product Information. Norplant System (levonorgestrel)" Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Lo/Ovral (ethinyl estradiol-norgestrel)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
- "Product Information. Demulen (ethinyl estradiol-ethynodiol)." Searle, Skokie, IL.
- Who Task Force on Long-acting Agents for Fertility Regulation "Metabolic side-effects of injectable depot-medroxyprogesterone acetate, 150 mg three-monthly, in undernourished lactating women." Bull World Health Organ 64 (1986): 587-94
Nome genérico: progesterone
Marca comercial: Crinone, Endometrin, FIRST-Progesterone VGS 200, Prochieve, First Progesterone MC10, Menopause Formula Progesterone, Prometrium
Sinônimos: Prochieve
Prochieve (Progesterone Vaginal 4% Gel) - hiperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - hiperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - hiperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - iperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - hyperlipidémie 
Prochieve (Progesterone Vaginal 4% Gel) - Hyperlipidämie 
Prochieve (Progesterone Vaginal 4% Gel) - hiperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - гиперлипидемия 
Prochieve (Progesterone Vaginal 4% Gel) - hyperlipidemia 
Prochieve (Progesterone Vaginal 4% Gel) - hiperlipidemi 
Prochieve (Progesterone Vaginal 4% Gel) - ارتفاع شحوم الدم 
Prochieve (Progesterone Vaginal 4% Gel) - 高脂血症